Nintedanib
Showing 201 - 215 of 215
Multiple Myeloma Trial (BIBF 1120 ES)
Completed
- Multiple Myeloma
- BIBF 1120 ES
- (no location specified)
Jul 17, 2014
Healthy Trial (BIBF 1120 capsules charge 1, BIBF 1120 capsules charge 2, BIBF 1120 drinking solution)
Completed
- Healthy
- BIBF 1120 capsules charge 1
- +2 more
- (no location specified)
Jul 17, 2014
NSCLC Trial (BIBF 1120, Paclitaxel, Carboplatin)
Completed
- Carcinoma, Non-Small-Cell Lung
- BIBF 1120
- +2 more
- (no location specified)
Jul 17, 2014
Healthy Trial (BIBF 1120)
Completed
- Healthy
- BIBF 1120
- (no location specified)
Jul 17, 2014
Prostatic Tumors Trial (BIBF 1120)
Completed
- Prostatic Neoplasms
- BIBF 1120
- (no location specified)
Jul 17, 2014
Healthy Trial (BIBF 1120 soft gelatine capsule, BIBF 1120 intravenous solution, Placebo ampoule)
Completed
- Healthy
- BIBF 1120 soft gelatine capsule
- +2 more
- (no location specified)
Jul 17, 2014
Healthy Trial (BIBF 1120 ES)
Completed
- Healthy
- BIBF 1120 ES
- (no location specified)
Jul 17, 2014
Tumors Trial (BIBF 1120)
Completed
- Tumors
- BIBF 1120
- (no location specified)
Jul 17, 2014
Tumors Trial (BIBF 1120)
Completed
- Tumors
- BIBF 1120
- (no location specified)
Jul 17, 2014
Prostatic Tumors Trial in United Kingdom (BIBF 1120, BIBW 2992, Sequential BIBF 1120 + BIBW 2992)
Completed
- Prostatic Neoplasms
- BIBF 1120
- +2 more
-
Belfast, United Kingdom
- +8 more
Jan 14, 2015
Acute Myeloid Leukemia Trial in Münster (triple kinase inhibitor BIBF1120)
Unknown status
- Acute Myeloid Leukemia
- triple kinase inhibitor BIBF1120
-
Münster, GermanyUniversitätsklinikum Münster, Medizinische Klinik und Poliklinik
Dec 10, 2013
Malignant Solid Tumour Trial in Freiburg (BIBF 1120)
Completed
- Malignant Solid Tumour
- BIBF 1120
-
Freiburg, GermanyKlinik für Tumorbiologie, Abteilung Internistische Onkologie
Sep 24, 2013
Tumors Trial in United States (BIBW 2992, BIBF 1120)
Completed
- Neoplasms
- BIBW 2992
- BIBF 1120
-
Scottsdale, Arizona
- +3 more
Aug 20, 2009